B4GALT1 cDNA variants and compositions comprising the same
AssigneesRegeneron Pharmaceuticals, Inc., University of Maryland, Baltimore
InventorsMay Montasser, Cristopher Van Hout, Alan Shuldiner, Giusy Della Gatta, Matthew Healy, Marja Puurunen
Life of this patent
Estimating the term…
Abstract
Variant B4GALT1 genomic, mRNA, and cDNA nucleic acid molecules, and polypeptides, methods of detecting the presence of these molecules, methods of modulating endogenous B4GALT1 genomic, mRNA, and cDNA nucleic acid molecules, and polypeptides, methods of ascertaining the risk of developing cardiovascular conditions by detecting the presence or absence of the variant B4GALT1 genomic, mRNA, and cDNA nucleic acid molecules, and polypeptides, and methods of treating cardiovascular conditions are provided herein.
Claims13
A cDNA molecule comprising a nucleotide sequence encoding a human Beta-1,4-galactosyltransferase 1 (B4GALT1) polypeptide, wherein the nucleotide sequence comprises SEQ ID NO:6.
Dependencies are inferred from the claim text.